Skip to main content
Fig. 3 | Arthritis Research & Therapy

Fig. 3

From: Predictive biomarkers for low-dose IL-2 therapy efficacy in systemic lupus erythematosus: a clinical analysis

Fig. 3

Clinical indicators for the prediction of SRI-4 after Ld-IL2 treatment in SLE patients. A Forest plot depicting the efficacy of Ld-IL2 treatment in responder and non-responder groups. B Receiver operator characteristic (ROC) curve of the ability of rash, renal involvement, CD4 + T cells, and complement 3 (C3) to predict an SRI-4 response with an AUC of 0.933. Ld-IL2: low-dose IL-2; SRI-4: SLE responder index-4

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us